World-class strategy for cancer
New ideas on therapies and care for living with cancer
Participants in this recent Policy Forum discussion, a collaboration between the New Statesman and Pfizer, discussed the progress that may be expected on the newly released Cancer Reform Strategy and that of its predecessor, the 2000 Cancer Plan.
Between the publication of these two documents, many new drug therapies became available – expensive therapies that have led to disparities between primary care trusts about patients’ eligibility for them.
The discussion centred on the issues of what we need to do on prevention, early diagnosis, better treatment, living with and beyond cancer, and the whole new survivorship agenda.
